Sesma, A.; Pardo, J.; Cruellas, M.; Gálvez, E.M.; Gascón, M.; Isla, D.; MartÃnez-Lostao, L.; Ocáriz, M.; Paño, J.R.; QuÃlez, E.;
et al. From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers 2020, 12, 2974.
https://doi.org/10.3390/cancers12102974
AMA Style
Sesma A, Pardo J, Cruellas M, Gálvez EM, Gascón M, Isla D, MartÃnez-Lostao L, Ocáriz M, Paño JR, QuÃlez E,
et al. From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers. 2020; 12(10):2974.
https://doi.org/10.3390/cancers12102974
Chicago/Turabian Style
Sesma, Andrea, Julián Pardo, Mara Cruellas, Eva M. Gálvez, Marta Gascón, Dolores Isla, Luis MartÃnez-Lostao, Maitane Ocáriz, José Ramón Paño, Elisa QuÃlez,
and et al. 2020. "From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy" Cancers 12, no. 10: 2974.
https://doi.org/10.3390/cancers12102974
APA Style
Sesma, A., Pardo, J., Cruellas, M., Gálvez, E. M., Gascón, M., Isla, D., MartÃnez-Lostao, L., Ocáriz, M., Paño, J. R., QuÃlez, E., RamÃrez, A., Torres-Ramón, I., Yubero, A., Zapata, M., & Lastra, R.
(2020). From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy. Cancers, 12(10), 2974.
https://doi.org/10.3390/cancers12102974
